AVANOS MEDICAL INC (AVNS) Forecast, Price Target & Analyst Ratings

NYSE:AVNS • US05350V1061

Current stock price

13.46 USD
0 (0%)
At close:
13.46 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AVANOS MEDICAL INC (AVNS).

Forecast Snapshot

Consensus Price Target

Price Target
N/A
N/A
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.15
Revenue Estimate
172.38M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
N/A
Upside
N/A
From current price of $13.46 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

AVNS Current Analyst RatingAVNS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

AVNS Historical Analyst RatingsAVNS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
AVNS was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about AVNS.
In the previous month the buy percentage consensus was at a similar level.
AVNS was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-05-07JMP SecuritiesReiterate Market Perform
2023-07-25KeybancDowngrade Overweight -> Sector Weight
2023-06-21StifelReiterate Hold -> Hold
2023-05-22CL KingInitiate Buy
2023-05-04Morgan StanleyMaintains Underweight
2023-02-22Morgan StanleyMaintains Underweight
2023-01-06Morgan StanleyMaintains Underweight
2022-11-03KeybancMaintains Overweight
2022-10-11Morgan StanleyMaintains Underweight
2022-08-10KeybancMaintains Overweight
2022-07-18StifelMaintains Hold
2022-07-15Morgan StanleyMaintains Underweight
2022-05-05Morgan StanleyMaintains Underweight
2022-02-24KeybancMaintains Overweight
2022-01-07Morgan StanleyMaintains Underweight
2021-08-04KeybancMaintains Overweight
2021-08-04Stephens & Co.Downgrade Overweight -> Equal-Weight
2021-08-04Morgan StanleyMaintains Underweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.15
Revenue Estimate
172.38M
Revenue Q2Q
2.91%
EPS Q2Q
-43.12%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
-0.29%
Revenue (3 Months)
-0.29%
EPS (1 Month)
-36.96%
EPS (3 Months)
-36.96%

Next Earnings Summary

AVNS is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 0.15 USD and the consensus revenue estimate is 172.38M USD.
The next earnings revenue estimate has been revised downward by 0.29% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027
Revenue
YoY % growth
AVNS revenue by date.AVNS revenue by date.
673.3M
-17.89%		687.8M
2.15%		701.2M
1.95%		724.2M
3.28%		754.8M
4.23%
EBITDA
YoY % growth
AVNS ebitda by date.AVNS ebitda by date.
53.6M
-56.67%		90.2M
68.28%		55.8M
-38.14%		166.97M
199.23%		182.58M
9.35%
EBIT
YoY % growth
AVNS ebit by date.AVNS ebit by date.
7.5M
-90.13%		44.7M
496.00%		16.9M
-62.19%		68.238M
303.78%		84.864M
24.36%
Operating Margin
AVNS operating margin by date.AVNS operating margin by date.
1.11%6.50%2.41%9.42%11.24%
EPS
YoY % growth
AVNS eps by date.AVNS eps by date.
1.38
-16.36%		1.26
-8.70%		0.94
-25.40%		1.02
8.62%		1.28
24.98%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.15
-43.12%		0.17
-2.20%		0.24
11.27%		0.26
-12.07%		0.01
-90.52%		0.02
-90.34%		0.04
-83.54%		0.05
-81.10%
Revenue
Q2Q % growth		172.38M
2.91%		178.7M
2.11%		182.68M
2.74%		189.21M
4.59%		217.66M
26.27%		226.8M
26.92%		233.02M
27.56%		240.97M
27.36%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		16.422M
59.44%		15.3M
512.00%		129.65M
129,550.00%		144.32M
3,508.00%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AVNS Yearly Revenue VS EstimatesAVNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
AVNS Yearly EPS VS EstimatesAVNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

AVANOS MEDICAL INC / AVNS Forecast FAQ

Can you provide the upcoming earnings date for AVANOS MEDICAL INC?

AVANOS MEDICAL INC (AVNS) will report earnings on 2026-05-04.

What are the consensus estimates for AVNS stock next earnings?

The consensus EPS estimate for the next earnings of AVANOS MEDICAL INC (AVNS) is 0.15 USD and the consensus revenue estimate is 172.38M USD.

How do analysts rate AVANOS MEDICAL INC (AVNS)?

The consensus rating for AVANOS MEDICAL INC (AVNS) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.